Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia (Q40748854)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2001

Language	Label	Description	Also known as
English	Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia	scientific article published on December 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

0 references

author name string

Wong A

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dukic-Stefanovic S

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Gasic-Milenkovic J

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Schinzel R

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Wiesinger H

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Riederer P

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Münch G

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1961-1967

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Inducible nitric oxide synthase activity of cloned murine microglial cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Glycation and microglial reaction in lesions of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Activation of transcriptionally active nuclear factor-kappaB by tumor necrosis factor-alpha and its inhibition by antioxidants in rat thyroid FRTL-5 cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Nitric oxide biochemistry

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Neuroprotective potential of aromatic alcohols against oxidative cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Differential regulation of microglial activation by propentofylline via cAMP signaling

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Advanced glycation endproducts stimulate the MAP‐kinase pathway in tubulus cell line LLC‐PK1

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01820.X

21 January 2018

Identifiers

10.1046/J.0953-816X.2001.01820.X

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40748854&oldid=2046994375"